About this trial
Colorectal cancer is the third most common cancer in men, after prostate and lung cancer. It represents 11.2% of all new cases of male cancer. In women, this cancer is the second most common after breast cancer (11.3% of all new cases of female cancer).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients treated for colonic and / or rectal resection in the oncological digestive surgery department of the Paoli-Calmettes Institute,
Patients over 18 years old,
Affiliation to a social security scheme, or beneficiary of such a scheme.
Disqualifiers
None
Trial population
adults treated ot to be treated for colonic and or rectal resection
Trial design
Cohort
Prospective
Treatments tested in this trial
obsevation
Other interventionprospective data collection for colonic or rectal surgery
Treatment groups
Trial outcomes
Primary outcomes
clinical events
to asses postoperative effects of colonic or rectal excision by collecting clinical events
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: